Report Detail
Worldwide Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027
- RnM3988483 |
- 05 June, 2020 |
- Global |
- 260 Pages |
- DPI Research |
- Medical Devices & Consumables
Worldwide Influenza Vaccines Market size is expected to exceed USD 7.5 billion by 2027.
Highlighted with 23 tables and 100 figures, this 260-page report “Worldwide Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027” is based on a comprehensive research of the worldwide influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the worldwide influenza vaccines market. The report provides historical market data for 2013 – 2019, and forecasts from 2020 until 2027. A comprehensive analysis has been done on market share with the percentage of all the segments.
The report contains a deep analysis of the worldwide influenza vaccines market with size in terms of both value and volume. The report provides a clear insight into current and future developments of the worldwide influenza vaccines market. The report also explores a detailed analysis of the children and adults vaccinated with influenza vaccines worldwide from 2013 to 2019 and forecasts to 2027. It provides essential insights into influenza vaccines market revenue for the top 21 regional and national, and forecast until 2027.
Key trends in terms of collaboration deals, merger & acquisitions, distribution, exclusive and licensing agreement are analyzed with details. The report also offers detailed information about the recruiting clinical trials statement by phase, trial status, study sponsor name and study phase. The report also investigates detailed insights about regulatory landscape including the approval process and an overview of the regulatory authorities in the United States, EU, and Japan. The report also delivers a detailed assessment of the latest happenings in the influenza vaccines market worldwide. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2027.
The report concludes with the profiles of the key players in the worldwide influenza vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, influenza vaccines sales value analysis, and recent development.
Other emerging players are making novel technology-based vaccines that are likely to affect the market share during the forecast period. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology, and recent development.
The Report Analyses the Market Based on Countries and Presents the Forecast in Terms of Value and Volume for the Next Seven Years. Countries Covered in the Report Include:
1) United States
2) Canada
3) Brazil
4) Germany
5) France
6) Italy
7) Spain
8) United Kingdom
9) Netherlands
10) Sweden
11) Denmark
12) Poland
13) Norway
14) Finland
15) Ireland
16) Belgium
17) Australia
18) New Zealand
19) Japan
20) China
21) India
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Sanofi Pasteur
• GlaxoSmithKline (GSK)
• Seqirus (CSL Limited)
• AstraZeneca
• Mylan
• Gamma Vaccines Pty Ltd.
• Hualan Biological Engineering Inc.
• Shanghai Institute of Biological Products Co., Ltd.
• BioDiem
• Novavax
• BiondVax Pharmaceuticals Ltd.
• Medicago
• Moderna Inc
• Pneumagen
• Daiichi–Sankyo
• Altimmune
• FluGen
• Imutex
Report Scope
• The Market Size of the Worldwide Influenza Vaccines Market with Seven Years Forecast
• The Market Size of the Regional and National Influenza Vaccines Market with Seven Years Forecast
• Scrutinizes the Worldwide Overall Persons Being Vaccinated with Influenza Vaccines
• Scrutinizes the Regional and National Persons Being Vaccinated with Influenza Vaccines
• Delivers a Latest Happenings in the Worldwide Influenza Vaccines Market
• Detailed Insights of the Regulatory Framework Including the Approval Process and an Overview of the Regulatory Authorities in the United States, EU, and Japan
• Provides Key Trends with Respect to Collaboration Deals, Merger & Acquisitions, Distribution, Exclusive and Licensing Agreement
• Reviews Most Recent Clinical Trials of the Influenza Vaccines
• A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development
• An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development
The Report Helps Answer the Following Questions:
• What is the current size of the worldwide influenza vaccines market? How much will this market be worth from 2020 to 2027?
• How many persons being vaccinated with influenza vaccines worldwide during 2013 – 2027?
• Which country is expected to hold the highest market share in the worldwide influenza vaccine market?
• What are the main drivers and restraints in the worldwide influenza vaccines market?
• What are the major deals happenings in the worldwide influenza vaccines market?
• Who are the top players and what are their activities, revenue, recent developments, and prospects?
• What are some of the most prominent influenza vaccines currently in development? What are their activities, phase, platform technology, and recent developments?
1. Executive Summary
2. Worldwide Number of Persons Vaccinated with Influenza Vaccines and Forecast (2013 – 2027)
3. Worldwide Influenza Vaccines Market Revenue and Forecast (2013 – 2027)
4. Worldwide Influenza Vaccines Market Share and Y–o–Y Growth (%)
- 4.1 Number of Persons Vaccinated with Influenza Vaccines Share,2013 – 2027(%)
- 4.2 Influenza Vaccines Market Share,2013 - 2027(%)
5. Worldwide Influenza Vaccines Market Drivers and Inhibitors
- 5.1 Market Drivers
- 5.2 Market Inhibitors
6. Worldwide Influenza Vaccines Market, By Geography (Volume and Value),2013 – 2027
- 6.1 United States
- 6.1.1 United States Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.1.2 United States Influenza Vaccines Market Revenue (2013 – 2027)
- 6.2 Canada
- 6.2.1 Canada Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.2.2 Canada Influenza Vaccines Market Revenue (2013 – 2027)
- 6.3 Germany
- 6.3.1 Germany Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.3.2 Germany Influenza Vaccines Market Revenue (2013 – 2027)
- 6.4 France
- 6.4.1 France Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.4.2 France Influenza Vaccines Market Revenue (2013 – 2027)
- 6.5 Italy
- 6.5.1 Italy Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.5.2 Italy Influenza Vaccines Market Revenue (2013 – 2027)
- 6.6 Spain
- 6.6.1 Spain Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.6.2 Spain Influenza Vaccines Market Revenue (2013 – 2027)
- 6.7 United Kingdom
- 6.7.1 United Kingdom Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.7.2 United Kingdom Influenza Vaccines Market Revenue (2013 – 2027)
- 6.8 Netherlands
- 6.8.1 Netherlands Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.8.2 Netherlands Influenza Vaccines Market Revenue (2013 – 2027)
- 6.9 Sweden
- 6.9.1 Sweden Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.9.2 Sweden Influenza Vaccines Market Revenue (2013 – 2027)
- 6.10 Denmark
- 6.10.1 Denmark Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.10.2 Denmark Influenza Vaccines Market Revenue (2013 – 2027)
- 6.11 Poland
- 6.11.1 Poland Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.11.2 Poland Influenza Vaccines Market Revenue (2013 – 2027)
- 6.12 Norway
- 6.12.1 Norway Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.12.2 Norway Influenza Vaccines Market Revenue (2013 – 2027)
- 6.13 Finland
- 6.13.1 Finland Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.13.2 Finland Influenza Vaccines Market Revenue (2013 – 2027)
- 6.14 Ireland
- 6.14.1 Ireland Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.14.2 Ireland Influenza Vaccines Market Revenue (2013 – 2027)
- 6.15 Belgium
- 6.15.1 Belgium Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.15.2 Belgium Influenza Vaccines Market Revenue (2013 – 2027)
- 6.16 Australia
- 6.16.1 Australia Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.16.2 Australia Influenza Vaccines Market Revenue (2013 – 2027)
- 6.17 New Zealand
- 6.17.1 New Zealand Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.17.2 New Zealand Influenza Vaccines Market Revenue (2013 – 2027)
- 6.18 Japan
- 6.18.1 Japan Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.18.2 Japan Influenza Vaccines Market Revenue (2013 – 2027)
- 6.19 Brazil
- 6.19.1 Brazil Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.19.2 Brazil Influenza Vaccines Market Revenue (2013 – 2027)
- 6.20 China
- 6.20.1 China Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.20.2 China Influenza Vaccines Market Revenue (2013 – 2027)
- 6.21 India
- 6.21.1 India Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.21.2 India Influenza Vaccines Market Revenue (2013 – 2027)
- 6.22 Rest of the World (ROW)
- 6.22.1 ROW Number of Persons Vaccinated with Influenza Vaccines (2013 – 2027)
- 6.22.2 ROW Influenza Vaccines Market Revenue (2013 – 2027)
7. Recent Development in the Worldwide Influenza Vaccines Market
8. Worldwide Influenza Vaccines Market – Regulatory System
- 8.1 United States
- 8.2 Europe
- 8.3 Japan
9. Major Deals in the Worldwide Influenza Vaccines Market
- 9.1 Merger and Acquisitions
- 9.2 Collaboration Deals
- 9.3 Licensing Agreement
- 9.4 Exclusive Agreement
- 9.5 Distribution Agreement
10. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
- 10.1 Year 2020
- 10.2 Year 2019
11. Key Companies Analysis
- 11.1 Sanofi Pasteur
- 11.1.1 Business Overview
- 11.1.2 Influenza Vaccines Portfolio
- 11.1.3 Influenza Vaccines Value Sales Analysis
- 11.1.4 Promising Influenza Vaccines in the Clinical Development
- 11.1.5 Recent Development
- 11.2 GlaxoSmithKline (GSK)
- 11.2.1 Business Overview
- 11.2.2 Influenza Vaccines Portfolio
- 11.2.3 Influenza Vaccines Sales Value Analysis
- 11.2.4 Recent Development
- 11.3 Seqirus (CSL Limited)
- 11.3.1 Business Overview
- 11.3.2 Influenza Vaccines Portfolios
- 11.3.3 Influenza Vaccines Sales Value Analysis
- 11.3.4 Promising Influenza Vaccines in the Clinical Development
- 11.3.5 Recent Development
- 11.4 AstraZeneca
- 11.4.1 Business Overview
- 11.4.2 Influenza Vaccines Portfolio
- 11.4.3 Influenza Vaccines Sales Value Analysis
- 11.4.4 Recent Development
- 11.5 Gamma Vaccines Pty Ltd
- 11.5.1 Business Overview
- 11.5.2 Influenza Vaccines Portfolio
- 11.5.3 Recent Development
- 11.6 Hualan Biological Engineering Inc
- 11.6.1 Business Overview
- 11.6.2 Influenza Vaccines Portfolio
- 11.6.3 Recent Development
- 11.7 Shanghai Institute of Biological Products Co., Ltd.
- 11.7.1 Business Overview
- 11.7.2 Influenza Vaccine Portfolio
- 11.8 Mylan
- 11.8.1 Business Overview
- 11.8.2 Influenza Vaccine Portfolio
- 11.9 BioDiem
- 11.9.1 Business Overview
- 11.9.2 Influenza Vaccine Portfolio
- 11.9.3 Recent Development
12. Emerging Players
- 12.1 Novavax
- 12.1.1 Business Overview
- 12.1.2 Promising Influenza Vaccines in the Clinical Development
- 12.1.3 Recent Development
- 12.2 BiondVax Pharmaceuticals Ltd.
- 12.2.1 Business Overview
- 12.2.2 Promising Influenza Vaccines in the Clinical Development
- 12.2.3 Recent Development
- 12.3 Medicago
- 12.3.1 Business Overview
- 12.3.2 Promising Influenza Vaccines in the Clinical Development
- 12.3.3 Recent Development
- 12.4 Moderna Inc
- 12.4.1 Business Overview
- 12.4.2 Promising Influenza Vaccines in the Clinical Development
- 12.4.3 Recent Development
- 12.5 Pneumagen
- 12.5.1 Business Overview
- 12.5.2 Promising Influenza Vaccines in the Clinical Development
- 12.5.3 Recent Development
- 12.6 Altimmune
- 12.6.1 Business Overview
- 12.6.2 Promising Influenza Vaccines in the Clinical Development
- 12.6.3 Recent Development
- 12.7 Daiichi Sankyo
- 12.7.1 Business Overview
- 12.7.2 Promising Influenza Vaccines in the Clinical Development
- 12.7.3 Recent Development
- 12.8 FluGen
- 12.8.1 Business Overview
- 12.8.2 Promising Influenza Vaccines in the Clinical Development
- 12.8.3 Recent Development
- 12.9 Imutex
- 12.9.1 Business Overview
Summary:
Get latest Market Research Reports on Worldwide Influenza Vaccines. Industry analysis & Market Report on Worldwide Influenza Vaccines is a syndicated market report, published as Worldwide Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027. It is complete Research Study and Industry Analysis of Worldwide Influenza Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
